Skip to content

ESD Home

TechCentury

Powered by

Engineering Society of Detroit Lawrence Technological University

Tag: Esperion

Pharmaceuticals

Esperion: Enough Cash On Hand To Bring Cholesterol-Buster To Market

ANN ARBOR — The pharma startup Esperion Therapeutics Inc. (Nasdaq: ESPR) told its investors this week that following a $200 million public stock sale in March, it “estimates that current …

Finance / Life Sciences

Esperion Sets Public Stock Offering

ANN ARBOR — Esperion Theapeutics Inc. (Nasdaq: ESPR), the developer of a new class of cholesterol-fighting drugs, has announced the intention to sell $85 million of its stock in a …

Health / Life Sciences

More Good News On Ann Arbor Firm's Cholesterol Drug

ANN ARBOR — Esperion Therapeutics Inc. (NASDAQ: ESPR) reported more positive “top-lline” results from the lates study of the effectiveness and safety of its ETC-1002 cholesterol drug in a Phase …

Read the magazine:

TechCentury
Advertise or Contribute an Article
Lawrence Technological University

Subscribe to TechCentury.com

Top Posts

  • Liquid Web Bought Out By Chicago Firm; Founding CEO To Step Down
  • Advanced seat from Lear on display at CES
  • Tour three of Frank Lloyd Wright’s Usonian houses June 4
  • Bosch Breaks Ground on Technical Center Expansion In Plymouth
  • Esperion boosts sales of cholesterol-busting drugs

Archives

Follow Us On

© The Engineering Society of Detroit   |   ABOUT